The treatment of germ cell tumors in children with combined modality therapy 

Molecular genetic alterations in endometrial cancer. 

Mechanisms of acquisition of molecular genetic changes during tumor development and progression 

Bone marrow derived mesenchymal stem cells promote survival and drug resistance in tumor cells 

Enhancing phenotype prediction through integrative analysis of heterogeneous microbiome studies 

Molecular genetic alterations in breast cancer 

The role of cellular senescence in tumor development 

A study of the excretion products of estrogen metabolism in the rat and the human, and the relationship with the human carcinoma of the cervix 

Contribution of cancer associated fibroblasts to cancer progression 

The role of α-catlulin during tumor progression and early mouse development 

Development of novel technology platforms for blood based diagnosis and cellular characterization in cancer 

Genes and hormonal factors involved in the development or recurrence of breast cancer 

Tri-specific T cell engager immunotherapy targeting tumor initiating cells 

Over-expression of EphB4 by cancer cells provides survival advantage by interrupting death receptor-mediated apoptotic pathways 

Magnetic resonance imaging (MRI) staging for breast cancer in a diverse population 

APOC2 presents a viable therapeutic target in cancer 

Cluster analysis of p53 mutational spectra 

HER-2/neu-mediated cell migration and invasion 

Survival trends and related outcomes of survivors of childhood and young adult cancer 

PD-L1-GM-CSF fusion protein-loaded DC vaccination activates PDL1-specific humoral and cellular immune responses 

Steatosis induces Wnt/β-catenin pathway to stimulate proliferation of hepatic tumor initiating cells and promote liver cancer development 

Let there be LIGHT: TNFSF14 immunomodulating properties for cancer immunotherapy 

Characterization of SEM-1, a seminoma cell line 

Studies of nanosecond pulsed power for modifications of biomaterials and nanomaterials (SWCNT) 

Quantification and modulation of cis-diamminedichloroplatinum (II) (cisplatin) binding to DNA and other subcellular components in vivo